RESEARCH
All products are supplied strictly for laboratory and research use only — not for human or veterinary use. By entering, you confirm you are 18 or older and agree to our Terms & Conditions.
Under 18? Leave this sitePathway research overview
A higher-level laboratory overview of GHRH signalling, pituitary growth-hormone release, growth-hormone receptor signalling and the wider IGF-axis research context.
The growth-hormone axis is a connected endocrine signalling framework studied at several levels. In simplified laboratory models, hypothalamic GHRH signalling is considered upstream of pituitary growth-hormone release; growth hormone then interacts with its receptor, while IGF-related signalling forms part of the wider downstream research context.
Researchers may isolate one stage, measure communication between stages or examine feedback relationships. The axis is therefore a framework for organising experiments, not evidence that every study material acts at the same receptor or produces an equivalent response.
STAGE 01
GHRH-receptor research examines ligand binding and receptor-associated signalling upstream of growth-hormone release. Assays may measure receptor activation, second messengers or related cellular responses under defined conditions.
STAGE 02
Pituitary models investigate how upstream signals relate to growth-hormone secretion. Cell systems, sampling intervals and release endpoints shape what can be concluded from an experiment.
STAGE 03
Growth-hormone receptor studies examine direct interaction with growth hormone and downstream pathways including JAK2–STAT signalling. This receptor context is distinct from the upstream GHRH receptor.
STAGE 04
IGF-related measurements may be used to study downstream endocrine signalling associated with the wider axis. IGF production, receptor activity and feedback are separate research questions and should not be treated as a single interchangeable endpoint.
A synthetic GHRH analogue positioned in upstream GHRH-receptor research. Its own molecular identity and compound-level context are covered separately.
View research pageA distinct synthetic GHRH analogue also studied in the upstream receptor context. Sharing that category does not make it equivalent to another analogue.
View research pageA recombinant polypeptide used for direct growth-hormone and growth-hormone-receptor research rather than as a GHRH-receptor analogue.
View research pageA GHRH analogue is used to investigate an upstream releasing-hormone receptor context. Recombinant HGH is used to examine growth hormone and its own receptor context directly. Results from one position should not be assigned to the other.
Materials can be related to the same axis while differing in molecular identity, receptor target and experimental role. Even compounds at the same pathway stage require separate identification and interpretation.
Findings can vary with species, cell system, receptor expression, concentration, exposure time, sampling schedule and the endpoint measured. Binding, secretion, receptor signalling and IGF-related measurements answer different questions.
Educational laboratory-research information only. This page does not provide dosing, administration, bodybuilding guidance, therapeutic claims, medical advice or human-use instructions.
Your cart is empty.